152 related articles for article (PubMed ID: 10363646)
1. Are there multiple proteolytic pathways contributing to c-Fos, c-Jun and p53 protein degradation in vivo?
Salvat C; Aquaviva C; Jariel-Encontre I; Ferrara P; Pariat M; Steff AM; Carillo S; Piechaczyk M
Mol Biol Rep; 1999 Apr; 26(1-2):45-51. PubMed ID: 10363646
[TBL] [Abstract][Full Text] [Related]
2. Complex mechanisms for c-fos and c-jun degradation.
Jariel-Encontre I; Salvat C; Steff AM; Pariat M; Acquaviva C; Furstoss O; Piechaczyk M
Mol Biol Rep; 1997 Mar; 24(1-2):51-6. PubMed ID: 9228281
[TBL] [Abstract][Full Text] [Related]
3. Differential directing of c-Fos and c-Jun proteins to the proteasome in serum-stimulated mouse embryo fibroblasts.
Salvat C; Jariel-Encontre I; Acquaviva C; Omura S; Piechaczyk M
Oncogene; 1998 Jul; 17(3):327-37. PubMed ID: 9690514
[TBL] [Abstract][Full Text] [Related]
4. Degradation of the proto-oncogene product c-Fos by the ubiquitin proteolytic system in vivo and in vitro: identification and characterization of the conjugating enzymes.
Stancovski I; Gonen H; Orian A; Schwartz AL; Ciechanover A
Mol Cell Biol; 1995 Dec; 15(12):7106-16. PubMed ID: 8524278
[TBL] [Abstract][Full Text] [Related]
5. Degradation of cellular and viral Fos proteins.
Acquaviva C; Ferrara P; Bossis G; Brockly F; Salvat C; Jariel-Encontre I; Piechaczyk M
Biochimie; 2001; 83(3-4):357-62. PubMed ID: 11295497
[TBL] [Abstract][Full Text] [Related]
6. Multiple degradation pathways for Fos family proteins.
Acquaviva C; Bossis G; Ferrara P; Brockly F; Jariel-Encontre I; Piechaczyk M
Ann N Y Acad Sci; 2002 Nov; 973():426-34. PubMed ID: 12485905
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitinylation of transcription factors c-Jun and c-Fos using reconstituted ubiquitinylating enzymes.
Hermida-Matsumoto ML; Chock PB; Curran T; Yang DC
J Biol Chem; 1996 Mar; 271(9):4930-6. PubMed ID: 8617766
[TBL] [Abstract][Full Text] [Related]
8. The structural determinants responsible for c-Fos protein proteasomal degradation differ according to the conditions of expression.
Ferrara P; Andermarcher E; Bossis G; Acquaviva C; Brockly F; Jariel-Encontre I; Piechaczyk M
Oncogene; 2003 Mar; 22(10):1461-74. PubMed ID: 12629509
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of RAS, JUN, FOS, and p53 oncoprotein expression in human colorectal adenomas and carcinomas.
Magrisso IJ; Richmond RE; Carter JH; Pross CB; Gilfillen RA; Carter HW
Lab Invest; 1993 Dec; 69(6):674-81. PubMed ID: 8264230
[TBL] [Abstract][Full Text] [Related]
10. Proteolysis by calpains: a possible contribution to degradation of p53.
Pariat M; Carillo S; Molinari M; Salvat C; Debüssche L; Bracco L; Milner J; Piechaczyk M
Mol Cell Biol; 1997 May; 17(5):2806-15. PubMed ID: 9111352
[TBL] [Abstract][Full Text] [Related]
11. c-Fos proto-oncoprotein is degraded by the proteasome independently of its own ubiquitinylation in vivo.
Bossis G; Ferrara P; Acquaviva C; Jariel-Encontre I; Piechaczyk M
Mol Cell Biol; 2003 Oct; 23(20):7425-36. PubMed ID: 14517309
[TBL] [Abstract][Full Text] [Related]
12. Clastosome: a subtype of nuclear body enriched in 19S and 20S proteasomes, ubiquitin, and protein substrates of proteasome.
Lafarga M; Berciano MT; Pena E; Mayo I; Castaño JG; Bohmann D; Rodrigues JP; Tavanez JP; Carmo-Fonseca M
Mol Biol Cell; 2002 Aug; 13(8):2771-82. PubMed ID: 12181345
[TBL] [Abstract][Full Text] [Related]
13. c-Fos degradation by the proteasome. An early, Bcl-2-regulated step in apoptosis.
He H; Qi XM; Grossmann J; Distelhorst CW
J Biol Chem; 1998 Sep; 273(39):25015-9. PubMed ID: 9737957
[TBL] [Abstract][Full Text] [Related]
14. Elevated ERK-MAP kinase activity protects the FOS family member FRA-1 against proteasomal degradation in colon carcinoma cells.
Vial E; Marshall CJ
J Cell Sci; 2003 Dec; 116(Pt 24):4957-63. PubMed ID: 14625389
[TBL] [Abstract][Full Text] [Related]
15. Degradation of c-Fos by the 26S proteasome is accelerated by c-Jun and multiple protein kinases.
Tsurumi C; Ishida N; Tamura T; Kakizuka A; Nishida E; Okumura E; Kishimoto T; Inagaki M; Okazaki K; Sagata N
Mol Cell Biol; 1995 Oct; 15(10):5682-7. PubMed ID: 7565719
[TBL] [Abstract][Full Text] [Related]
16. The ubiquitin-proteasome pathway.
Roos-Mattjus P; Sistonen L
Ann Med; 2004; 36(4):285-95. PubMed ID: 15224655
[TBL] [Abstract][Full Text] [Related]
17. Cellular and viral Fos proteins are degraded by different proteolytic systems.
Acquaviva C; Salvat C; Brockly F; Bossis G; Ferrara P; Piechaczyk M; Jariel-Encontre I
Oncogene; 2001 Feb; 20(8):942-50. PubMed ID: 11314029
[TBL] [Abstract][Full Text] [Related]
18. Identification of a C-terminal tripeptide motif involved in the control of rapid proteasomal degradation of c-Fos proto-oncoprotein during the G(0)-to-S phase transition.
Acquaviva C; Brockly F; Ferrara P; Bossis G; Salvat C; Jariel-Encontre I; Piechaczyk M
Oncogene; 2001 Nov; 20(51):7563-72. PubMed ID: 11709728
[TBL] [Abstract][Full Text] [Related]
19. Evasion from proteasomal degradation by mutated Fos proteins expressed from FBJ-MSV and FBR-MSV osteosarcomatogenic retroviruses.
Acquaviva C; Bossis G; Ferrara P; Brockly F; Jariel-Encontre I; Piechaczyk M
Biochem Pharmacol; 2002 Sep; 64(5-6):957-61. PubMed ID: 12213592
[TBL] [Abstract][Full Text] [Related]
20. mdm2 and bax, downstream mediators of the p53 response, are degraded by the ubiquitin-proteasome pathway.
Chang YC; Lee YS; Tejima T; Tanaka K; Omura S; Heintz NH; Mitsui Y; Magae J
Cell Growth Differ; 1998 Jan; 9(1):79-84. PubMed ID: 9438391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
